Target To Heal The Mucosal Lining, Prevent Colon Cancer

by Julia Samuel on November 23, 2017 at 1:50 PM
Target To Heal The Mucosal Lining, Prevent Colon Cancer

Mucosal healing or the absence of inflammatory and ulcerative lesions in all segments of the colon, should be the end goal in treating patients with ulcerative colitis according to an editorial in the journal Gastrointestinal Endoscopy.

The authors believe the analysis in the study by Flores and colleagues, Impact of Mucosal Inflammation on Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis: A Systematic Review and Meta-Analysis, reaffirms the suspicion that ongoing colonic inflammation not only increases the risk of abnormal growth of colorectal tissue (pre-cancer and/or cancer), but also may affect guidelines for surveillance colonoscopies.


"There are several reasons to target mucosal healing in patients with ulcerative colitis, reducing cancer risk being one of them. If we are truly aiming for mucosal healing, this may mean more aggressive medical therapy early in the treatment course even if histologic activity is not necessarily reflected in patients' symptoms," explained corresponding author Francis A. Farraye, MD, MSc, professor of medicine at Boston University School of Medicine.

The authors said the pivotal role played by mucosal healing in driving favorable outcomes in ulcerative colitis is acknowledged, but whether this bar should unequivocally be set at histologic healing and if so, at what level, remains to be established.

"Arguably, the first step is to better define histologic remission and healing In addition, the use of validated endoscopic scoring systems that provide objectivity, uniformity and standardization in reporting mucosal appearances, augmenting clinical decision making and ultimately affecting appropriate treatment targets and desirable patient outcomes," said Farraye, clinical director in the section of gastroenterology at Boston Medical Center.

Source: Eurekalert
Font : A-A+



Recommended Readings

Latest Research News

South Korea's 2050 Forecast: Negative Growth Amid Low Fertility
South Korea's total fertility rate, averaging the number of children a woman aged 15-49 has in her lifetime, dropped to 0.81.
New Immunotherapy for Psoriasis & Vitiligo
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
2050 Forecast: 1.06 Billion Individuals to Face 'Other' Musculoskeletal Disorders
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.
Gene Therapies Can Disrupt Gaucher Disease Drug Market
Experts consulted by GlobalData anticipate a significant overhaul in the Gaucher disease scenario because of forthcoming gene therapies in development.
NASH Cases Expected to Hit 26.55 Million in 7MM by 2032
Within the seven major markets, 12% to 20% of diagnosed prevalent NASH cases present severe liver damage (stage 4 liver fibrosis), denoting cirrhosis.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Target To Heal The Mucosal Lining, Prevent Colon Cancer Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests